A unique Finnish study has investigated the link between growth conditions in the womb and cardiovascular disease in adulthood. The results highlight the importance of shared genetic factors between mother and child.

Hereditary risk of colorectal cancer should be assessed in a more comprehensive way, shows a study led by researchers at the University of Helsinki, Finland. Using comprehensive genetic information, the age and frequency of screening could be tailored based on individual risk.

The largest genetic study of gestational diabetes to date has led to a discovery of nine novel genetic regions linked to this severe and common pregnancy complication. The results shed light on previously unknown physiological mechanisms related to the development of diabetes that involve adaptive changes in the brain during pregnancy.

We are happy to announce that the FinnGen data freeze 10 results and summary statistics were made publicly available on December 18, 2023!

A massive genetic study involving almost 800,000 participants has uncovered genetic factors that contribute to the use of sleep medications, shedding new light on the intricate relationship between sleep problems and psychiatric conditions.

We teamed-up with experts on data visualisation from Aalto University to co-create a new accessible and engaging communication resource. Scroll through the website to learn about the FinnGen project, its goals, processes and its impact in Finland and around the world. Don't miss out – explore now and expand your horizons!

Results based on the FinnGen data are presented in almost 40 talks or posters during the 2023 Annual Meeting of the American Society of Human Genetics (ASHG) in Washington DC, November 1-5. Come and meet our researchers!

The FinnGen research consortium has successfully collected and generated genomic data from 500,000 individuals. Now, the project will continue its search for genetic clues to disease progression and explore the biological mechanism of the genetic signals uncovered in the first stages of the project.

FinnGen has met its target of collecting 500,000 participants on schedule. We want to thank each and every Finnish biobank sample donor for making medical research possible and the biobanks for their excellent cooperation over the past six years!

We are happy to announce that the FinnGen data freeze 9 results and summary statistics are now publicly available!